Parkman Healthcare Partners’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-161,705
| Closed | -$7.71M | – | 100 |
|
|
2024
Q2 | $7.71M | Buy |
161,705
+20,206
| +14% | +$963K | 1.03% | 38 |
|
|
2024
Q1 | $6.13M | Sell |
141,499
-69,901
| -33% | -$3.03M | 0.75% | 46 |
|
|
2023
Q4 | $10.7M | Buy |
211,400
+51,897
| +33% | +$2.63M | 1.51% | 22 |
|
|
2023
Q3 | $7.24M | Buy |
159,503
+6,451
| +4% | +$293K | 1.33% | 26 |
|
|
2023
Q2 | $6.28M | Buy |
153,052
+1,891
| +1% | +$77.6K | 1.09% | 28 |
|
|
2023
Q1 | $5.4M | Buy |
151,161
+10,046
| +7% | +$359K | 1.18% | 33 |
|
|
2022
Q4 | $5.33M | Sell |
141,115
-100,830
| -42% | -$3.81M | 1.42% | 23 |
|
|
2022
Q3 | $10.7M | Buy |
241,945
+67,645
| +39% | +$2.99M | 3.04% | 8 |
|
|
2022
Q2 | $6.45M | Buy |
+174,300
| New | +$6.45M | 2.38% | 15 |
|
|
2022
Q1 | – | Sell |
-80,238
| Closed | -$2.44M | – | 87 |
|
|
2021
Q4 | $2.44M | Sell |
80,238
-56,142
| -41% | -$1.71M | 0.54% | 48 |
|
|
2021
Q3 | $4.57M | Hold |
136,380
| – | – | 1.16% | 28 |
|
|
2021
Q2 | $5.44M | Buy |
136,380
+30,583
| +29% | +$1.22M | 1.19% | 32 |
|
|
2021
Q1 | $4.76M | Buy |
105,797
+30,379
| +40% | +$1.37M | 1.1% | 28 |
|
|
2020
Q4 | $4.26M | Buy |
+75,418
| New | +$4.26M | 1.09% | 36 |
|